175 related articles for article (PubMed ID: 9590125)
21. Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma.
Matsuda H; Strebel FR; Kaneko T; Stephens LC; Danhauser LL; Jenkins GN; Toyota N; Bull JM
Anticancer Res; 1996; 16(3A):1117-21. PubMed ID: 8702222
[TBL] [Abstract][Full Text] [Related]
22. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.
Page RL; Macy DW; Ogilvie GK; Rosner GL; Dewhirst MW; Thrall DE; Withrow SJ; McEntee MC; Cline JM; Heidner GL
Int J Hyperthermia; 1992; 8(2):187-97. PubMed ID: 1573308
[TBL] [Abstract][Full Text] [Related]
23. Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.
Novotney CA; Page RL; Macy DW; Dewhirst MW; Ogilvie GK; Withrow SJ; McEntee MC; Heidner GL; Allen SA; Thrall DE
J Vet Intern Med; 1992; 6(4):245-9. PubMed ID: 1522556
[TBL] [Abstract][Full Text] [Related]
24. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
25. Optimal duration of whole body hyperthermia when combined with cis-diamminedichloroplatinum(II).
Makino M; Ohno S; Sakaguchi Y; Kaneko T; Strebel F; Jenkins G; Bull J
Int J Oncol; 1997 Feb; 10(2):329-32. PubMed ID: 21533380
[TBL] [Abstract][Full Text] [Related]
26. Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours.
Harrington KJ; Rowlinson-Busza G; Uster PS; Stewart JS
Cancer Chemother Pharmacol; 2000; 46(1):10-8. PubMed ID: 10912572
[TBL] [Abstract][Full Text] [Related]
27. Absence of whole body hyperthermia effect on cisplatin distribution in spontaneous canine tumors.
Page RL; Lee J; Riviere JE; Dodge RK; Thrall DE; Dewhirst MW
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1097-102. PubMed ID: 7607930
[TBL] [Abstract][Full Text] [Related]
28. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations.
Ostberg JR; Repasky EA
Int J Hyperthermia; 2000; 16(1):29-43. PubMed ID: 10669315
[TBL] [Abstract][Full Text] [Related]
30. In vitro thermo-chemosensitivity screening of spontaneous human tumors: significant potentiation for cisplatin but not adriamycin.
Calabro A; Singletary SE; Tucker S; Boddie A; Spitzer G; Cavaliere R
Int J Cancer; 1989 Mar; 43(3):385-90. PubMed ID: 2925271
[TBL] [Abstract][Full Text] [Related]
31. [Combined effects of gamma rays, cis-diamminedichloroplatinum (CDDP) and systemic hyperthermia mastocytoma transplanted into muscle in the mouse].
Nakamura W; Komatsu K; Kageyama K
C R Seances Soc Biol Fil; 1985; 179(4):558-62. PubMed ID: 2938683
[TBL] [Abstract][Full Text] [Related]
32. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82].
Xu M; Lin C; Liang X
Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):689-93. PubMed ID: 11798837
[TBL] [Abstract][Full Text] [Related]
34. Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.
Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
Int J Cancer; 2001 Feb; 91(4):550-4. PubMed ID: 11251980
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
[TBL] [Abstract][Full Text] [Related]
36. Optimal duration of whole body hyperthermia when combined with cis-diaminne-1,1-cychlobutane dicarboxylate platinum (II) (carboplatin).
Kaneko T; Sakaguchi Y; Makino M; Matsuda H; Strebel FR; Jenkins GN; Bull JM
Anticancer Res; 1997; 17(3C):1897-901. PubMed ID: 9216642
[TBL] [Abstract][Full Text] [Related]
37. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model.
Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN
Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB
Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model.
Goldberg SN; Saldinger PF; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Kruskal JB
Radiology; 2001 Aug; 220(2):420-7. PubMed ID: 11477246
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
